High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis delta

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Romeo, Raffaella ^a   Foglieni, Barbara ^b   Casazza, Giovanni ^c   Spreafico, Marta ^b   Colombo, Massimo ^a   Prati, Daniele ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b A MANZONI HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; SINGLE STRANDED RNA; VIRUS DNA; VIRUS RNA;

ADULT; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; QUALITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; VIRUS REPLICATION; BLOOD; CARCINOMA, HEPATOCELLULAR; COMPLICATION; DELTA AGENT HEPATITIS; GENETICS; ITALY; LIVER NEOPLASMS; VIREMIA; VIROLOGY;

CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DISEASE PROGRESSION; DNA, VIRAL; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS D; HEPATITIS D, CHRONIC; HEPATITIS DELTA VIRUS; HUMANS; ITALY; LIVER CIRRHOSIS; LIVER NEOPLASMS; RNA, VIRAL; VIREMIA;

EID: 84899079442     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092062     Document Type: Article

References (31)

1. Rizzetto M (1983) The delta agent. Hepatology 3: 729-737.
2. Farci P (2003) Delta hepatitis: an update. J Hepatol 39 (Suppl 1): S212-219.
3. Hadziyannis SJ (1997) Review: hepatitis delta. J Gastroenterol Hepatol 12: 289-298.
4. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, et al (2000) Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology 32: 824-827.
5. Wedemeyer H, Heidrich B, Manns MP (2007) Hepatitis D virus infection - not a vanishing disease in Europe. Hepatology 45: 1331-1332. (Pubitemid 46775802)
6. Erhardt A, Knut R, Sagir A, Kirschberg O, Heintges T, et al. (2003) Socioepidemiological data on hepatitis delta in a German university clinic - increase in patients from Eastern Europe and the former Soviet Union. Z Gastroenterol 41: 523-526. (Pubitemid 36798996)
7. Cross TJ, Rizzi P, Horner M, Jolly A, Hussain MJ, et al. (2008) The increasing prevalence of hepatitis Delta virus (HDV) infection in South London. J Med Virol 80: 277-282.
8. Romeo R, Del Ninno E, Rumi MG, Russo A, Sangiovanni A, et al. (2009) A 28-year study of the course of hepatitis D infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 136: 1629-1638.
9. Ottobrelli A, Marzano A, Smedile A, Recchia S, Salizzoni M, et al. (1991) Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology 101: 1649-1655.
10. Taylor JM (2006) Hepatitis delta virus. Virology 344: 71-76.
11. Zachou K, Yurdaydin C, Drebber U, Dalekos GN, Erhardt A, et al. (2010) Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver International 30: 430-437.
12. Colombo M, Cambieri R, Rumi MG, Ronchi G, Del Ninno E, et al. (1983) Long-term Delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis. Gastroenterology 85: 235-239. (Pubitemid 13070903)
13. Kodani M, Martin A, Mixson-Hayden T, Drobeniuc J, Gish RR, et al. (2013) One-step real-time PCR assay for the detection and quantitation of hepatitis D virus RNA. J Virol Methods 193: 531-535.
14. The French METAVIR cooperative study group (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20: 15-20.
15. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surgery 60: 643-649.
16. Colombo M, de Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, et al. (1991) Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 325: 675-680.
17. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona EASL Conference. J Hepatol 35: 421-430. (Pubitemid 32844200)
18. Peters RL (1976) Pathology of hepatocellular carcinoma. In: Okuda K, Peters RL, eds. Hepatocellular Carcinoma. New York: John Wiley. 107p.
19. Portal hypertension III (2001) Proceedings of the Third Baveno International Consensus Workshop on Definition, Methodology and Therapeutic Strategies. De Franchis R, ed. London: Blackwell Science. 1p.
20. Salerno F, Angeli P, Bernardi M, Laffi G, Riggio O, et al. (1999) Clinical practice guidelines for the management of cirrhotic patients with ascites. Committee on Ascites of the Italian Association for the Study of the Liver. Ital J Gastroenterol Hepatol 7: 626-634. (Pubitemid 29527856)
21. Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Yamashiro T, et al. (2001) Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection. J Med Virol 65: 478-484. (Pubitemid 32959073)
22. Hadziyannis SJ, Sherman M, Lieberman HM, Shafritz DA (1985) Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers. Hepatology 5: 544-547. (Pubitemid 15029721)
23. Iloeje UH, Yang HI, Su J, Jen CL, You SL, et al. (2006) Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 130: 678-686. (Pubitemid 43374518)
24. Wu JC, Chen TZ, Huang YS, Yen FS, Ting LT, et al. (1995) Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction. Gastroenterology 108: 796-802.
25. Aslan N, Yurdaydin C, Bozkaya H, Baglan P, Bozdayi AM, et al. (2003) Analysis and function of delta-hepatitis virus-specific cellular immune responses. J Hepatol (S2); 38: 15-16.
26. Huang YH, Tao MH, Hu CP, Syu WJ, Wu JC (2004) Identification of novel HLA-A*0201-restricted CD8 + T-cell epitopes on hepatitis delta virus. J Gen Virol 85: 3089-3098.
27. Niro GA, Smedile A, Andriulli A, Rizzetto M, Gerin JL, et al. (1997) The predominance of hepatitis Delta virus genotype I among chronically infected Italian patients. Hepatology 25: 728-734. (Pubitemid 27106461)
28. Williams V, Brichler S, Radjef N, Lebon P, Goffard A, et al. (2009) Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene. J Gen Virol 90: 2759-2767.
29. Heidrich B, Serrano BC, Idilman R, Kabaçam G, Bremer B, et al. (2012) HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome. Liver International epub 1-11.
30. Pollicino T, Raffa G, Santantonio T, Gaeta GB, Iannello G, et al. (2011) Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta virus. J Virol 85: 432-439.
31. Schaper M, Rodriguez-Frias F, Jardi R, Tabernero D, Homs M, et al. (2010) Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. J Hepatol 52: 658-664.